Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial

2.50
Hdl Handle:
http://hdl.handle.net/10547/593510
Title:
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial
Authors:
von Haehling, Stephan; Schefold, Joerg C.; Jankowska, Ewa A.; Springer, Jochen; Vazir, Ali; Kalra, Paul R.; Sandek, Anja; Fauler, Günter; Stojakovic, Tatjana; Trauner, Michael; Ponikowski, Piotr; Volk, Hans-Dieter; Doehner, Wolfram; Coats, Andrew J.S.; Poole-Wilson, Philip A.; Anker, Stefan D.
Abstract:
This study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF).
Affiliation:
Charité Medical School; Military Hospital, Wroclaw; University of East Anglia; National Heart and Lung Institute; Portsmouth Hospitals NHS Trust; Medical University of Graz; Medical University of Vienna; IRCCS San Raffaele
Citation:
von Haehling, S. et al (2012) 'Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial' J. Am. Coll. Cardiol. 59 (6):585-92
Publisher:
American College of Cardiology
Journal:
Journal of the American College of Cardiology
Issue Date:
7-Feb-2012
URI:
http://hdl.handle.net/10547/593510
DOI:
10.1016/j.jacc.2011.10.880
PubMed ID:
22300693
Additional Links:
http://content.onlinejacc.org/article.aspx?articleid=1201106
Type:
Article
Language:
en
ISSN:
1558-3597
Appears in Collections:
IHR Institute for Health Research

Full metadata record

DC FieldValue Language
dc.contributor.authorvon Haehling, Stephanen
dc.contributor.authorSchefold, Joerg C.en
dc.contributor.authorJankowska, Ewa A.en
dc.contributor.authorSpringer, Jochenen
dc.contributor.authorVazir, Alien
dc.contributor.authorKalra, Paul R.en
dc.contributor.authorSandek, Anjaen
dc.contributor.authorFauler, Günteren
dc.contributor.authorStojakovic, Tatjanaen
dc.contributor.authorTrauner, Michaelen
dc.contributor.authorPonikowski, Piotren
dc.contributor.authorVolk, Hans-Dieteren
dc.contributor.authorDoehner, Wolframen
dc.contributor.authorCoats, Andrew J.S.en
dc.contributor.authorPoole-Wilson, Philip A.en
dc.contributor.authorAnker, Stefan D.en
dc.date.accessioned2016-01-15T11:16:16Zen
dc.date.available2016-01-15T11:16:16Zen
dc.date.issued2012-02-07en
dc.identifier.citationvon Haehling, S. et al (2012) 'Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial' J. Am. Coll. Cardiol. 59 (6):585-92en
dc.identifier.issn1558-3597en
dc.identifier.pmid22300693en
dc.identifier.doi10.1016/j.jacc.2011.10.880en
dc.identifier.urihttp://hdl.handle.net/10547/593510en
dc.description.abstractThis study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF).en
dc.language.isoenen
dc.publisherAmerican College of Cardiologyen
dc.relation.urlhttp://content.onlinejacc.org/article.aspx?articleid=1201106en
dc.rightsArchived with thanks to Journal of the American College of Cardiologyen
dc.subjectursodeoxycholic aciden
dc.subjectendothelial functionen
dc.subjectinflammatory markersen
dc.subjectchronic heart failureen
dc.subject.meshAgeden
dc.subject.meshBile Acids and Saltsen
dc.subject.meshBiomarkersen
dc.subject.meshBlood Flow Velocityen
dc.subject.meshChromatography, High Pressure Liquiden
dc.subject.meshCross-Over Studiesen
dc.subject.meshDouble-Blind Methoden
dc.subject.meshEndothelium, Vascularen
dc.subject.meshExercise Toleranceen
dc.subject.meshFollow-Up Studiesen
dc.subject.meshHanden
dc.subject.meshHeart Failureen
dc.subject.meshHumansen
dc.subject.meshInterleukin-6en
dc.subject.meshLegen
dc.subject.meshLiver Function Testsen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPlethysmographyen
dc.subject.meshProspective Studiesen
dc.subject.meshStroke Volumeen
dc.subject.meshTreatment Outcomeen
dc.subject.meshTumor Necrosis Factor-alphaen
dc.subject.meshUrsodeoxycholic Aciden
dc.titleUrsodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trialen
dc.typeArticleen
dc.contributor.departmentCharité Medical Schoolen
dc.contributor.departmentMilitary Hospital, Wroclawen
dc.contributor.departmentUniversity of East Angliaen
dc.contributor.departmentNational Heart and Lung Instituteen
dc.contributor.departmentPortsmouth Hospitals NHS Trusten
dc.contributor.departmentMedical University of Grazen
dc.contributor.departmentMedical University of Viennaen
dc.contributor.departmentIRCCS San Raffaeleen
dc.identifier.journalJournal of the American College of Cardiologyen

Related articles on PubMed

All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.